
Keywords: Hepatocellular carcinoma (HCC); Transarterial chemoembolization (TACE); Biliary complications; BilomaTACE, transarterial chemoembolization; HCC, hepatocellular carcinoma; AFP, alpha-fetoprotein; MDCT, multi-detector computed tomography; MRI, magnetic reso